Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6

Satoshi Yamaori, Yasuka Okamoto, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition November 2011, 39 (11) 2049-2056; DOI: https://doi.org/10.1124/dmd.111.041384
Satoshi Yamaori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuka Okamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikuo Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhito Watanabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 39 no. 11 2049-2056
DOI 
https://doi.org/10.1124/dmd.111.041384
PubMed 
21821735

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 26, 2011
  • Accepted August 5, 2011
  • Published online October 18, 2011.

Article Versions

  • Earlier version (August 5, 2011 - 09:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Satoshi Yamaori,
  2. Yasuka Okamoto,
  3. Ikuo Yamamoto and
  4. Kazuhito Watanabe
  1. Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan (S.Y., Y.O., K.W.); Department of Hygienic Chemistry, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, Japan (I.Y.); and Organization for Frontier Research in Preventive Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan (K.W.)
  1. Address correspondence to:
    Dr. Kazuhito Watanabe, Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3, Kanagawa-machi, Kanazawa 920-1181, Japan. E-mail: k-watanabe{at}hokuriku-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 2017317422
Sep 2017176124
Oct 2017266739
Nov 20172815126
Dec 20172511717
Jan 20183413029
Feb 20182210535
Mar 20182714032
Apr 20182916931
May 20183143144
Jun 20183228448
Jul 20183119149
Aug 20182235851
Sep 20184855660
Oct 20182344068
Nov 20182931992
Dec 201827710524
Jan 20192551134
Feb 20191701731
Mar 20192271144
Apr 2019198641
May 20192081552
Jun 20192081253
Jul 20192351961
Aug 20191632359
Oct 20191992156
Nov 20192452052
Dec 2019123412
Jan 20201691130
Feb 2020971013
Mar 2020135517
May 20201991629
Jun 2020121211
Jul 2020148914
Aug 202084813
Sep 2020115816
Oct 20201441018
Nov 2020126615
Dec 20201671217
Jan 2021120714
Feb 20211811319
Mar 20211211412
Apr 2021190514
May 20211221017
Jun 20211161322
Jul 20211241226
Aug 20211311017
Sep 202175610
Oct 20211151215
Nov 2021101716
Dec 20211231018
Jan 20221221411
Feb 2022861010
Mar 20221051416
Apr 20221251713
May 2022126740
Jun 202269545
Jul 2022138326
Aug 202297116
Sep 2022133229
Oct 20221031821
Nov 202212494
Dec 20229789
Jan 2023152125

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (11)
Drug Metabolism and Disposition
Vol. 39, Issue 11
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INHIBITION OF CYP2D6 BY PHYTOCANNABINOIDS

Satoshi Yamaori, Yasuka Okamoto, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2049-2056; DOI: https://doi.org/10.1124/dmd.111.041384

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

INHIBITION OF CYP2D6 BY PHYTOCANNABINOIDS

Satoshi Yamaori, Yasuka Okamoto, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2049-2056; DOI: https://doi.org/10.1124/dmd.111.041384
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics